Ozempic Lawsuit in North Carolina (GLP-1 Claims)

What North Carolina residents should know

North Carolina residents with GLP-1 injury claims are generally not limited to North Carolina state court. Most filed cases are transferred into the federal multidistrict litigation, MDL-3094, before Judge Karen S. Marston in the Eastern District of Pennsylvania, which held 4,022 pending actions as of September 1, 2026.

North Carolina law still matters: the state's filing deadline, damages rules, and procedural law can shape an individual claim even when the case is litigated in the MDL.

North Carolina's coverage reversal and the Ozempic litigation

North Carolina residents' federal GLP-1 injury cases are transferred into MDL-3094 in the U.S. District Court for the Eastern District of Pennsylvania for coordinated proceedings. North Carolina Medicaid removed GLP-1 weight-management drugs (Wegovy, Zepbound, Saxenda) from coverage in October 2025 during a state budget impasse, then reinstated that coverage in December 2025. North Carolina Attorney General Jeff Jackson also joined a February 2025 letter from more than three dozen state attorneys general urging the FDA to act against counterfeit and illegally compounded GLP-1 drugs.

Sources: NC Medicaid — reinstating GLP-1 coverage for weight management (Dec. 2025); Multistate attorneys general letter to the FDA on GLP-1 drugs (Feb. 19, 2025).

Possible eligibility factors

• Documented use of a GLP-1 medication (prescription and pharmacy records from North Carolina providers).
• A diagnosis such as gastroparesis, ileus, or bowel obstruction — commonly supported by a gastric emptying study, endoscopy, imaging, or hospitalization records.
• Injury timing consistent with medication use.
• Filing within the deadline that applies to the claim under North Carolina law.

How North Carolina claims proceed

Most North Carolina GLP-1 cases are filed in or transferred to MDL-3094 in the Eastern District of Pennsylvania for coordinated proceedings. An August 28 court order rescheduled the Rule 702 expert-admissibility hearing for September 14–18, 2026; bellwether trial dates have not yet been set. North Carolina's general personal injury limitations period is 3 years (N.C. Gen. Stat. § 1-52), but accrual and discovery-rule questions are fact-specific for injuries that develop during ongoing medication use.

What records support Ozempic claims in North Carolina?

• Prescription, pharmacy, insurance, or provider records showing Ozempic or another GLP-1 medication and dates of use.
• Emergency room, hospital, gastroenterology, imaging, gastric-emptying, surgery, or follow-up records for the alleged injury.
• Records showing diagnosis timing for gastroparesis, bowel obstruction, ileus, aspiration, or related complications.
• Medication history, dose changes, side-effect reports, provider messages, and documents that help connect use and symptoms.

What exposure and legal context matter in North Carolina?

North Carolina residents may have been prescribed Ozempic, Wegovy, Rybelsus, Saxenda, Mounjaro, Zepbound, or Trulicity through endocrinologists, primary care practices, weight-management clinics, telehealth services, or hospital systems across the state.

Where are North Carolina Ozempic cases handled?

Living in North Carolina does not necessarily mean the case will be filed only in North Carolina. Claims may be evaluated by national firms, filed in federal court, coordinated through MDL proceedings, or handled through another legal process.

Federal courts in North Carolina

• Eastern District of North Carolina
• Middle District of North Carolina
• Western District of North Carolina

What is the filing deadline for Ozempic lawsuits in North Carolina?

For a North Carolina resident researching Ozempic claims, the starting point is usually North Carolina's general personal injury period: 3 years under N.C. Gen. Stat. § 1-52. That is only a starting point, not a final legal deadline for every person.

The real filing deadline can depend on diagnosis date, when the injury and possible cause were discovered, exposure location, wrongful-death issues, prior claim paperwork, and whether the case is filed directly, transferred to an MDL, or handled through another process.

Discovery-rule note: North Carolina applies discovery-based accrual to many latent injury claims (§ 1-52(16)).

How long do North Carolina residents have to file?

North Carolina's personal injury statute of limitations applicable to product liability claims is 3 years (N.C. Gen. Stat. § 1-52). Accrual timing, tolling, and repose periods can still change the real deadline in an individual case.

• Filing period: 3 years — N.C. Gen. Stat. § 1-52.
• Discovery rule: North Carolina applies discovery-based accrual to many latent injury claims (§ 1-52(16)).
• Statute of repose: North Carolina applies a 12-year statute of repose to product liability actions (§ 1-46.1).

Because the controlling deadline depends on diagnosis date, discovery facts, exposure history, wrongful-death rules, and how the claim is filed, only a licensed attorney can confirm the deadline that applies to a specific situation. This page is general legal information, not legal advice.

What should North Carolina residents ask a lawyer?

• Which GLP-1 medication and injury records do you need for an initial review?
• Do I need a gastric-emptying study, hospitalization record, imaging report, or specialist diagnosis?
• How do the Rule 702 schedule and lack of bellwether trial dates affect current claim review?
• How do state filing deadlines apply to my medication and symptom timeline?
• Would my claim be handled locally, nationally, or through the MDL?
• Are there upfront costs?